Beatrix Stelte-Ludwig

USPTO Granted Patents = 27 (Patent Applications = 29)

CIPO Patents = 2 (Patent Applications = 23)

EPO Patents = 8 (Patent Applications = 39)

Average Co-Inventor Count = 9.0

ph-index = 8

Forward Citations = 161(Granted Patents)

Location History:

Wuelfrath, DE (2001 - 2003)
Wulfrath, DE (2002 - 2014)
Wülfrath, DE (2002 - 2024)

Company Filing History:

15 out of 378

Bayer Pharma Aktiengesellschaft

patents

10 out of 12,160

Bayer Aktiengesellschaft

patents

4 out of 132

Seattle Genetics, Inc.

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12144865 - Antibody drug conjugates with enzymatically cleavable groups (2024-11-19),

2. 12065497 - Methods of treatment using CCR8 antibodies (2024-08-20),

3. 12059472 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups (2024-08-13),

4. 11806404 - Site specific homogeneous with KSP inhibitors (2023-11-07),

5. 11685714 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups (2023-06-27),

6. 11660351 - Antibody drug conjugates (ADCs) having enzymatically cleavable groups (2023-05-30),

7. 11643469 - Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies (2023-05-09),

8. 11478554 - Antibody drug conjugates (ADCS) having enzymatically cleavable groups (2022-10-25),

9. 11433140 - Specific antibody drug conjugates (ADCs) having KSP inhibitors (2022-09-06),

10. 11123439 - Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups (2021-09-21),

11. 11071788 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies (2021-07-27),

12. 11001636 - Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies (2021-05-11),

13. 10973923 - Site specific homogeneous with KSP inhibitors (2021-04-13),

14. 10744205 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies (2020-08-18),

15. 10485880 - Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies (2019-11-26),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with well-structured articles on various figures in these fields. If you have any requests regarding these specific topics, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.